Flow Neuroscience
Company · Malmö, Sweden
At-home tDCS headset for depression, paired with a behavioural therapy app.
Flow delivers transcranial direct current stimulation to the frontal cortex in short daily sessions. It is approved as a medical device for depression in the UK and EU.
In the news
RegulationNeuromodulation
FDA approves Flow's headset as the first at-home brain stimulation treatment for depression
The FL-100 tDCS headset can be prescribed for moderate to severe major depression, alone or alongside medication, with US launch expected in 2026.